{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:48:36Z","timestamp":1791679716845,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Arginine vasopressin (AVP) is a non-adrenergic vasopressor increasingly used in the management of shock. While it restores arterial pressure, its effects on the microcirculation remain uncertain, with potential for reduced regional perfusion and tissue oxygenation. The aim of this systematic review is to evaluate the effects of intravenous AVP and its analogues on microcirculatory perfusion across different haemodynamic conditions and vascular beds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of MEDLINE, EMBASE, and Web of Science was conducted. Animal and human publications evaluating the effects of intravenous AVP or analogues on microcirculatory perfusion assessed with in vivo microcirculatory imaging or flowmetry techniques were included. Publications were grouped by haemodynamic condition and vascular bed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 1693 records, 39 publications (31 animal, 7 human, 1 combined) were included, comprising 43 study-units and 152 individual measurements. Overall perfusion was decreased in 33%, unchanged in 48%, and increased in 19% of measurements, compared with baseline, saline, or other vasopressors. By haemodynamic condition, perfusion was decreased\/unchanged\/increased (n=study-units; % of measurements) in physiological conditions (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914: 57\/38\/4), vasodilatory or septic shock (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923: 24\/55\/21; versus baseline, fluid resuscitation or noradrenaline), haemorrhagic shock (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093: 17\/17\/67; versus baseline, saline or noradrenaline), cardiac dysfunction or arrest (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092: 0\/67\/33; versus adrenaline or noradrenaline) and cirrhosis-related portal hypertension (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091: 0\/0\/100). Across vascular beds: gastrointestinal tract (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918: 30\/42\/27), kidney (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099: medulla 77\/23\/0, cortex 27\/64\/9), sublingual bed (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097: 19\/68\/13), cerebral cortex (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092: 0\/67\/33), cutaneous bed (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096: 42\/42\/17), and conjunctiva (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091, 100\/0\/0).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AVP and its analogues reduced microcirculatory perfusion most consistently under physiological conditions, whereas effects in vasodilatory or septic shock were more heterogeneous. Across vascular beds, the highest proportion of measurements showing reduced perfusion was in the renal medulla. These results highlight the divergent effects of vasopressin across vascular beds and clinical conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-026-00983-5","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:32:28Z","timestamp":1791667948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of vasopressin and its analogues on microcirculatory perfusion: a systematic review"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0749-8866","authenticated-orcid":false,"given":"Judith","family":"van Zwol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Kruijsse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Vidal Itriago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N. T.","family":"Hemmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"van den Brom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"983_CR1","doi-asserted-by":"publisher","unstructured":"Prescott HC, Antonelli M, Alhazzani W, et al (2026) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Intensive Care Med 52:863\u2013936. https:\/\/doi.org\/10.1007\/s00134-026-08361-1","DOI":"10.1007\/s00134-026-08361-1"},{"key":"983_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s13054-025-05540-2","volume":"29","author":"Q Lajoye","year":"2025","unstructured":"Lajoye Q, Orieux A, Boyer A, Prevel R, Jozwiak M (2025) Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise? Crit Care 29:333","journal-title":"Crit Care"},{"key":"983_CR3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.107.728840","volume":"118","author":"CB Overgaard","year":"2008","unstructured":"Overgaard CB, Dzav\u00edk V (2008) Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 118:1047\u20131056","journal-title":"Circulation"},{"key":"983_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","volume":"202","author":"RF Stolk","year":"2020","unstructured":"Stolk RF, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden AE, Gerretsen J, Schambergen R, Ruth MM, van der Hoeven JG, van Leeuwen H, Pickkers P, Kox M (2020) Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis. Am J Respir Crit Care Med 202:830\u2013842","journal-title":"Am J Respir Crit Care Med"},{"key":"983_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","volume":"35","author":"LK Barrett","year":"2007","unstructured":"Barrett LK, Singer M, Clapp LH (2007) Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 35:33\u201340","journal-title":"Crit Care Med"},{"key":"983_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/cc2337","volume":"7","author":"CL Holmes","year":"2003","unstructured":"Holmes CL, Landry DW, Granton JT (2003) Science review: Vasopressin and the cardiovascular system part 1\u2013receptor physiology. Crit Care 7:427\u2013434","journal-title":"Crit Care"},{"key":"983_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063068","author":"M Glava\u0161","year":"2022","unstructured":"Glava\u0161 M, Gitlin-Domagalska A, D\u0119bowski D, Ptaszy\u0144ska N, \u0141\u0119gowska A, Rolka K (2022) Vasopressin and its analogues: from natural hormones to multitasking peptides. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23063068","journal-title":"Int J Mol Sci"},{"key":"983_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1161\/01.RES.67.4.1017","volume":"67","author":"S Vanner","year":"1990","unstructured":"Vanner S, Jiang MM, Brooks VL, Surprenant A (1990) Characterization of vasopressin actions in isolated submucosal arterioles of the intestinal microcirculation. Circ Res 67:1017\u20131026","journal-title":"Circ Res"},{"key":"983_CR9","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1152\/physrev.00035.2011","volume":"92","author":"T-a Koshimizu","year":"2012","unstructured":"Koshimizu T-a, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A (2012) Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems. Physiol Rev 92:1813\u20131864","journal-title":"Physiol Rev"},{"issue":"Suppl 3","key":"983_CR10","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/cc14726","volume":"19","author":"C Ince","year":"2015","unstructured":"Ince C (2015) Hemodynamic coherence and the rationale for monitoring the microcirculation. Crit Care 19(Suppl 3):S8","journal-title":"Crit Care"},{"key":"983_CR11","first-page":"267","volume":"26","author":"J Bakker","year":"2020","unstructured":"Bakker J, Ince C (2020) Monitoring coherence between the macro and microcirculation in septic shock. Curr Opin Crit Care 26:267\u2013272","journal-title":"Curr Opin Crit Care"},{"key":"983_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.atssr.2023.09.009","volume":"2","author":"D Manzur-Sandoval","year":"2024","unstructured":"Manzur-Sandoval D, Gopar-Nieto R, Torres-Pulido A, P\u00e9rez-Manjarrez AA, Hurtado-Belizario KSA, Riveros-Nina DG, Quirazco-C\u00f3rdova RE, Utrilla-\u00c1lvarez JD, Elizalde-Silva JL, Rojas-Velasco G, Ospina-Tasc\u00f3n GA (2024) Dissociation between measures of macrocirculation and microcirculation in patients undergoing cardiac surgical procedure. Ann Thorac Surg Short Rep 2:131\u2013135","journal-title":"Ann Thorac Surg Short Rep"},{"key":"983_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-C\u00f4t\u00e9 EP (2018) Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA 319:1889\u20131900","journal-title":"JAMA"},{"key":"983_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","volume":"45","author":"M Nagendran","year":"2019","unstructured":"Nagendran M, Russell JA, Walley KR, Brett SJ, Perkins GD, Hajjar L, Mason AJ, Ashby D, Gordon AC (2019) Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med 45:844\u2013855","journal-title":"Intensive Care Med"},{"key":"983_CR15","doi-asserted-by":"crossref","unstructured":"Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, Melo RR, Sundin MR, Grande SM, Gaiotto FA, Pomerantzeff PM, Dallan LO, Franco RA, Nakamura RE, Lisboa LA, de Almeida JP, Gerent AM, Souza DH, Gaiane MA, Fukushima JT, Park CL, Zambolim C, Rocha Ferreira GS, Strabelli TM, Fernandes FL, Camara L, Zeferino S, Santos VG, Piccioni MA, Jatene FB, Costa Auler JO Jr., Filho RK (2017) Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology 126:85\u201393","DOI":"10.1097\/ALN.0000000000001434"},{"key":"983_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-020-0628-2","volume":"10","author":"J Demiselle","year":"2020","unstructured":"Demiselle J, Fage N, Radermacher P, Asfar P (2020) Vasopressin and its analogues in shock states: a review. Ann Intensive Care 10:9","journal-title":"Ann Intensive Care"},{"key":"983_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.826446","volume":"9","author":"M Jozwiak","year":"2022","unstructured":"Jozwiak M, Geri G, Laghlam D, Boussion K, Dolladille C, Nguyen LS (2022) Vasopressors and risk of acute mesenteric ischemia: a worldwide pharmacovigilance analysis and comprehensive literature review. Front Med (Lausanne) 9:826446","journal-title":"Front Med (Lausanne)"},{"key":"983_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877\u2013887","journal-title":"N Engl J Med"},{"key":"983_CR19","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1513\/AnnalsATS.201604-259OC","volume":"13","author":"EA Vail","year":"2016","unstructured":"Vail EA, Gershengorn HB, Hua M, Walkey AJ, Wunsch H (2016) Epidemiology of Vasopressin Use for Adults with Septic Shock. Ann Am Thorac Soc 13:1760\u20131767","journal-title":"Ann Am Thorac Soc"},{"key":"983_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"983_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","volume":"38","author":"JH Schiavo","year":"2019","unstructured":"Schiavo JH (2019) PROSPERO: An International Register of Systematic Review Protocols. Med Ref Serv Q 38:171\u2013180","journal-title":"Med Ref Serv Q"},{"key":"983_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"key":"983_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"983_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JAC Sterne","year":"2016","unstructured":"Sterne JAC, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan A-W, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JPT (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"983_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/publications14010004","author":"E Gualdi-Russo","year":"2026","unstructured":"Gualdi-Russo E, Zaccagni L (2026) The Newcastle\u2013Ottawa scale for assessing the quality of studies in systematic reviews. Publications. https:\/\/doi.org\/10.3390\/publications14010004","journal-title":"Publications"},{"key":"983_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/SHK.0000000000001357","volume":"53","author":"LM van Loon","year":"2020","unstructured":"van Loon LM, Stolk RF, van der Hoeven JG, Veltink PH, Pickkers P, Lemson J, Kox M (2020) Effect of vasopressors on the macro- and microcirculation during systemic inflammation in humans in vivo. Shock (Augusta, Ga) 53:171\u2013174","journal-title":"Shock (Augusta, Ga)"},{"key":"983_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/cc4845","volume":"10","author":"G Luckner","year":"2006","unstructured":"Luckner G, D\u00fcnser MW, Stadlbauer KH, Mayr VD, Jochberger S, Wenzel V, Ulmer H, Pajk W, Hasibeder WR, Friesenecker B, Knotzer H (2006) Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care 10:R40","journal-title":"Crit Care"},{"issue":"5","key":"983_CR28","doi-asserted-by":"publisher","first-page":"R217","DOI":"10.1186\/cc10453","volume":"15","author":"A Morelli","year":"2011","unstructured":"Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, Di Russo A, D\u2019Egidio A, Landoni G, Lombrano MR, Botticelli L, Valentini A, Zangrillo A, Pietropaoli P, Westphal M (2011) Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock. Critical care (London, England) 15:R217","journal-title":"Critical care (London, England)"},{"key":"983_CR29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1042\/cs0710633","volume":"71","author":"PG Wiles","year":"1986","unstructured":"Wiles PG, Grant PJ, Davies JA (1986) The differential effect of arginine vasopressin on skin blood flow in man. Clin Sci (Lond) 71:633\u2013638","journal-title":"Clin Sci (Lond)"},{"key":"983_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.6061\/clinics\/2017(12)06","volume":"72","author":"APM Nascente","year":"2017","unstructured":"Nascente APM, Freitas FGR, Bakker J, Bafi AT, Ladeira RT, Azevedo LCP, Lima A, Machado FR (2017) Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline. Clin (Sao Paulo Brazil) 72:750\u2013757","journal-title":"Clin (Sao Paulo Brazil)"},{"key":"983_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1399-6576.2008.01900.x","volume":"53","author":"A Nygren","year":"2009","unstructured":"Nygren A, Thor\u00e9n A, Ricksten SE (2009) Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock. Acta Anaesthesiol Scand 53:581\u2013588","journal-title":"Acta Anaesthesiol Scand"},{"key":"983_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00134-011-2148-x","volume":"37","author":"A Morelli","year":"2011","unstructured":"Morelli A, Donati A, Ertmer C, Rehberg S, Orecchioni A, Di Russo A, Pelaia P, Pietropaoli P, Westphal M (2011) Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock. Intensive Care Med 37:963\u2013969","journal-title":"Intensive Care Med"},{"key":"983_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF02779273","volume":"26","author":"Y Saeki","year":"1991","unstructured":"Saeki Y, Nagatomi N, Kobayashi T, Hiratani S, Shiomi S, Arakawa T, Kamata T, Kobayashi K (1991) Effects of vasopressin on gastric mucosal blood flow in portal hypertension. Gastroenterol Japonica 26:90\u201392","journal-title":"Gastroenterol Japonica"},{"key":"983_CR34","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0016-5085(83)80068-7","volume":"85","author":"C Holliger","year":"1983","unstructured":"Holliger C, Radzyner M, Knoblauch M (1983) Effects of glucagon, vasoactive intestinal peptide, and vasopressin on villous microcirculation and superior mesenteric artery blood flow of the rat. Gastroenterology 85:1036\u20131043","journal-title":"Gastroenterology"},{"key":"983_CR35","doi-asserted-by":"publisher","first-page":"H168","DOI":"10.1152\/ajpheart.01235.2004","volume":"289","author":"H Knotzer","year":"2005","unstructured":"Knotzer H, Pajk W, Maier S, Ladurner R, Kleinsasser A, Wenzel V, D\u00fcnser MW, Ulmer H, Hasibeder WR (2005) Arginine vasopressin reduces intestinal oxygen supply and mucosal tissue oxygen tension. Am J Physiol Heart Circ Physiol 289:H168\u2013173","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"983_CR36","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1152\/japplphysiol.00900.2014","volume":"118","author":"AB Kildal","year":"2015","unstructured":"Kildal AB, Stenberg TA, Sanden E, Myrmel T, How O-J (2015) Prolonged observation time reveals temporal fluctuations in the sublingual microcirculation in pigs given arginine vasopressin. J Appl Physiol (Bethesda Md: 1985) 118:965\u2013970","journal-title":"J Appl Physiol (Bethesda Md: 1985)"},{"key":"983_CR37","doi-asserted-by":"publisher","first-page":"H1792","DOI":"10.1152\/ajpheart.00283.2004","volume":"287","author":"B Friesenecker","year":"2004","unstructured":"Friesenecker B, Tsai AG, D\u00fcnser MW, Mayr AJ, Martini J, Knotzer H, Hasibeder W, Intaglietta M (2004) Oxygen distribution in microcirculation after arginine vasopressin-induced arteriolar vasoconstriction. Am J Physiol Heart Circ Physiol 287:H1792-1800","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"983_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00004872-200103001-00019","volume":"19","author":"AG Correia","year":"2001","unstructured":"Correia AG, Denton KM, Evans RG (2001) Effects of activation of vasopressin-V1-receptors on regional kidney blood flow and glomerular arteriole diameters. J Hypertens 19:649\u2013657","journal-title":"J Hypertens"},{"key":"983_CR39","doi-asserted-by":"crossref","unstructured":"Cowley AW Jr., Skelton MM, Kurth TM (1998) Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure. Am J Physiol 275:R1420-1424","DOI":"10.1152\/ajpregu.1998.275.5.R1420"},{"key":"983_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1365-201x.2000.00741.x","volume":"169","author":"RG Evans","year":"2000","unstructured":"Evans RG, Madden AC, Denton KM (2000) Diversity of responses of renal cortical and medullary blood flow to vasoconstrictors in conscious rabbits. Acta Physiol Scand 169:297\u2013308","journal-title":"Acta Physiol Scand"},{"key":"983_CR41","doi-asserted-by":"crossref","unstructured":"Franchini KG, Cowley AW Jr. (1996) Sensitivity of the renal medullary circulation to plasma vasopressin. Am J Physiol 271:R647-653","DOI":"10.1152\/ajpregu.1996.271.3.R647"},{"key":"983_CR42","doi-asserted-by":"crossref","unstructured":"Franchini KG, Mattson DL, Cowley AW Jr. (1997) Vasopressin modulation of medullary blood flow and pressure-natriuresis-diuresis in the decerebrated rat. Am J Physiol 272:R1472-1479","DOI":"10.1152\/ajpregu.1997.272.5.R1472"},{"key":"983_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/cc4922","volume":"10","author":"BE Friesenecker","year":"2006","unstructured":"Friesenecker BE, Tsai AG, Martini J, Ulmer H, Wenzel V, Hasibeder WR, Intaglietta M, D\u00fcnser MW (2006) Arteriolar vasoconstrictive response: comparing the effects of arginine vasopressin and norepinephrine. Crit Care 10:R75","journal-title":"Crit Care"},{"issue":"1","key":"983_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13054-019-2643-y","volume":"23","author":"R Truse","year":"2019","unstructured":"Truse R, Grewe S, Herminghaus A, Schulz J, Weber APM, Mettler-Altmann T, Bauer I, Picker O, Vollmer C (2019) Exogenous vasopressin dose-dependently modulates gastric microcirculatory oxygenation in dogs via V1A receptor. Crit Care 23:353. https:\/\/doi.org\/10.1186\/s13054-019-2643-y","journal-title":"Critical care (London, England)"},{"key":"983_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jocs.12242","volume":"29","author":"H Bomberg","year":"2014","unstructured":"Bomberg H, Bierbach B, Flache S, Scheuer C, Nov\u00e1k M, Sch\u00e4fers HJ, Menger MD (2014) Vasopressin induces rectosigmoidal mucosal ischemia during cardiopulmonary bypass. J Card Surg 29:108\u2013115","journal-title":"J Card Surg"},{"key":"983_CR46","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/00000542-200509000-00014","volume":"103","author":"V Faivre","year":"2005","unstructured":"Faivre V, Kaskos H, Callebert J, Losser MR, Milliez P, Bonnin P, Payen D, Mebazaa A (2005) Cardiac and renal effects of levosimendan, arginine vasopressin, and norepinephrine in lipopolysaccharide-treated rabbits. Anesthesiology 103:514\u2013521","journal-title":"Anesthesiology"},{"issue":"6","key":"983_CR47","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/cc6197","volume":"11","author":"V Krejci","year":"2007","unstructured":"Krejci V, Hiltebrand LB, Jakob SM, Takala J, Sigurdsson GH (2007) Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow. Critical care (London, England) 11:R129","journal-title":"Critical care (London, England)"},{"key":"983_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/01.CCM.0000104201.62736.12","volume":"32","author":"M Westphal","year":"2004","unstructured":"Westphal M, Freise H, Kehrel BE, Bone H-G, Van Aken H, Sielenkamper AW (2004) Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 32:194\u2013200","journal-title":"Crit Care Med"},{"key":"983_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtcvs.2012.03.014","volume":"145","author":"H Bomberg","year":"2013","unstructured":"Bomberg H, Bierbach B, Flache S, Wagner I, Gl\u00e4ser L, Groesdonk HV, Menger MD, Sch\u00e4fers HJ (2013) Endothelin and vasopressin influence splanchnic blood flow distribution during and after cardiopulmonary bypass. J Thorac Cardiovasc Surg 145:539\u2013547","journal-title":"J Thorac Cardiovasc Surg"},{"key":"983_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mvr.2013.09.001","volume":"97","author":"K Wafa","year":"2015","unstructured":"Wafa K, Lehmann C, Wagner L, Drzymulski I, Wegner A, Pavlovic D (2015) Desmopressin improves intestinal functional capillary density and decreases leukocyte activation in experimental endotoxemia. Microvasc Res 97:98\u2013104","journal-title":"Microvasc Res"},{"key":"983_CR51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/anae.70049","volume":"81","author":"AH Jufar","year":"2026","unstructured":"Jufar AH, May CN, Furukawa T, Evans RG, Cochrane AD, Marino B, Raman J, McCall PR, Hulst A, Hood SG, Trask-Marino A, Bellomo R, Miles LF, Lankadeva YR (2026) Effects of noradrenaline, vasopressin, phenylephrine or metaraminol on kidney and brain microcirculation in ovine cardiopulmonary bypass: a randomised trial. Anaesthesia 81:383\u2013394","journal-title":"Anaesthesia"},{"key":"983_CR52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/01.anes.0000267599.02140.86","volume":"106","author":"LB Hiltebrand","year":"2007","unstructured":"Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH (2007) Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology 106:1156\u20131167","journal-title":"Anesthesiology"},{"key":"983_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00003246-200301000-00033","volume":"31","author":"P Asfar","year":"2003","unstructured":"Asfar P, Pierrot M, Veal N, Moal F, Oberti F, Croquet V, Douay O, Gallois Y, Saumet J-L, Alquier P, Cales P (2003) Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 31:215\u2013220","journal-title":"Crit Care Med"},{"key":"983_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257034","volume":"16","author":"J Schulz","year":"2021","unstructured":"Schulz J, Bauer I, Herminghaus A, Picker O, Truse R, Vollmer C (2021) Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: a randomized, placebo-controlled, blinded trial. PLoS One 16:e0257034","journal-title":"PLoS One"},{"key":"983_CR55","doi-asserted-by":"crossref","unstructured":"Marcus C, Hof S, Gesing A, Thelen P, Orzol S, Vocke A, Schulz J, Kuebart AKC, Truse R, Vollmer C, Bauer I, Picker O, Herminghaus A (2026) Milrinone and levosimendan improve microvascular perfusion in septic rats: a randomized, placebo-controlled trial. Intensive Care Med Exp 14","DOI":"10.1186\/s40635-026-00881-w"},{"key":"983_CR56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00134-008-1058-z","volume":"34","author":"T Kopel","year":"2008","unstructured":"Kopel T, Losser MR, Faivre V, Payen D (2008) Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits. Intensive Care Med 34:1313\u20131320","journal-title":"Intensive Care Med"},{"key":"983_CR57","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1097\/01.CCM.0000218812.73741.6C","volume":"34","author":"Y Nakajima","year":"2006","unstructured":"Nakajima Y, Baudry N, Duranteau J, Vicaut E (2006) Effects of vasopressin, norepinephrine, and L-arginine on intestinal microcirculation in endotoxemia. Crit Care Med 34:1752\u20131757","journal-title":"Crit Care Med"},{"key":"983_CR58","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jss.2014.01.053","volume":"188","author":"X Qiu","year":"2014","unstructured":"Qiu X, Huang Y, Xu J, Qiu H, Yang Y (2014) Effects of terlipressin on microcirculation of small bowel mesentery in rats with endotoxic shock. J Surg Res 188:503\u2013509","journal-title":"J Surg Res"},{"key":"983_CR59","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/01.CCM.0000139708.10718.E3","volume":"32","author":"M Albert","year":"2004","unstructured":"Albert M, Losser M-R, Hayon D, Faivre V, Payen D (2004) Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 32:1891\u20131898","journal-title":"Crit Care Med"},{"key":"983_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/10731190601188257","volume":"35","author":"AT Cheung","year":"2007","unstructured":"Cheung AT, To PL, Chan DM, Ramanujam S, Barbosa MA, Chen PC, Driessen B, Jahr JS, Gunther RA (2007) Comparison of treatment modalities for hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol 35:173\u2013190","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"983_CR61","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.injury.2015.10.075","volume":"47","author":"R Gonz\u00e1lez","year":"2016","unstructured":"Gonz\u00e1lez R, Urbano J, L\u00f3pez J, Solana MJ, Botr\u00e1n M, Garc\u00eda A, Fern\u00e1ndez SN, L\u00f3pez-Herce J (2016) Microcirculatory alterations during haemorrhagic shock and after resuscitation in a paediatric animal model. Injury 47:335\u2013341","journal-title":"Injury"},{"key":"983_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/SHK.0b013e31826b64e5","volume":"38","author":"R Lima","year":"2012","unstructured":"Lima R, Villela NR, Bouskela E (2012) Microcirculatory effects of selective receptor blockade during hemorrhagic shock treatment with vasopressin: experimental study in the hamster dorsal chamber. Shock (Augusta Ga) 38:493\u2013498","journal-title":"Shock (Augusta Ga)"},{"key":"983_CR63","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/SHK.0000000000001747","volume":"56","author":"T Klein","year":"2021","unstructured":"Klein T, Grandmougin D, Liu Y, Orlowski S, Albuisson E, Tran NG, Levy B (2021) Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO. Shock (Augusta Ga) 56:473\u2013478","journal-title":"Shock (Augusta Ga)"},{"key":"983_CR64","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/01.CCM.0000280427.76175.D2","volume":"35","author":"G Ristagno","year":"2007","unstructured":"Ristagno G, Sun S, Tang W, Castillo C, Weil MH (2007) Effects of epinephrine and vasopressin on cerebral microcirculatory flows during and after cardiopulmonary resuscitation. Crit Care Med 35:2145\u20132149","journal-title":"Crit Care Med"},{"key":"983_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4161\/viru.26482","volume":"5","author":"D De Backer","year":"2014","unstructured":"De Backer D, Orbegozo Cortes D, Donadello K, Vincent JL (2014) Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence 5:73\u201379","journal-title":"Virulence"},{"key":"983_CR66","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","volume":"21","author":"CD Kemp","year":"2012","unstructured":"Kemp CD, Conte JV (2012) The pathophysiology of heart failure. Cardiovasc Pathol 21:365\u2013371","journal-title":"Cardiovasc Pathol"},{"key":"983_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40635-021-00389-5","volume":"9","author":"ALI van Leeuwen","year":"2021","unstructured":"van Leeuwen ALI, Dekker NAM, Van Slyke P, de Groot E, Vervloet MG, Roelofs J, van Meurs M, van den Brom CE (2021) The effect of targeting Tie2 on hemorrhagic shock-induced renal perfusion disturbances in rats. Intensive Care Med Exp 9:23","journal-title":"Intensive Care Med Exp"},{"key":"983_CR68","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamasurg.2019.2884","volume":"154","author":"CA Sims","year":"2019","unstructured":"Sims CA, Holena D, Kim P, Pascual J, Smith B, Martin N, Seamon M, Shiroff A, Raza S, Kaplan L, Grill E, Zimmerman N, Mason C, Abella B, Reilly P (2019) Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial. JAMA Surg 154:994\u20131003","journal-title":"JAMA Surg"},{"key":"983_CR69","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0014-2999(98)00345-8","volume":"352","author":"C Varga","year":"1998","unstructured":"Varga C, P\u00e1v\u00f3 I, Lamarque D, Szepes Z, Kiss J, Kar\u00e1csony G, L\u00e1szl\u00f3 FA, L\u00e1szl\u00f3 F (1998) Endogenous vasopressin increases acute endotoxin shock-provoked gastrointestinal mucosal injury in the rat. Eur J Pharmacol 352:257\u2013261","journal-title":"Eur J Pharmacol"},{"key":"983_CR70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00000539-200107000-00003","volume":"93","author":"MW D\u00fcnser","year":"2001","unstructured":"D\u00fcnser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93:7\u201313","journal-title":"Anesth Analg"},{"key":"983_CR71","doi-asserted-by":"crossref","unstructured":"Park F, Zou AP, Cowley AW Jr. (1998) Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla. Hypertension 32:896\u2013901","DOI":"10.1161\/01.HYP.32.5.896"},{"key":"983_CR72","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00134-023-07098-5","volume":"49","author":"RR Bruno","year":"2023","unstructured":"Bruno RR, Wollborn J, Fengler K, Flick M, Wunder C, Allg\u00e4uer S, Thiele H, Schemmelmann M, Hornemann J, Moecke HME, Demirtas F, Palici L, Franz M, Saugel B, Kattan E, De Backer D, Bakker J, Hernandez G, Kelm M, Jung C (2023) Direct assessment of microcirculation in shock: a randomized-controlled multicenter study. Intensive Care Med 49:645\u2013655","journal-title":"Intensive Care Med"},{"key":"983_CR73","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1093\/eurheartj\/ehq324","volume":"31","author":"CA den Uil","year":"2010","unstructured":"den Uil CA, Lagrand WK, van der Ent M, Jewbali LS, Cheng JM, Spronk PE, Simoons ML (2010) Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 31:3032\u20133039","journal-title":"Eur Heart J"},{"key":"983_CR74","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jointm.2026.01.010","volume":"6","author":"C Ince","year":"2026","unstructured":"Ince C, Ergin B, Montomoli J, D\u00f6ring M, Boegborn N, van Dam W, Marchena G, Dilken O, de Vos A, Khaki H, Gommers D, Hilty MP (2026) The OxyCam: a novel hand-held vital microscope for quantitative measurement of microcirculatory perfusion and oxygenation. J Intensive Med 6:382\u2013390","journal-title":"J Intensive Med"},{"key":"983_CR75","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13613-025-01607-z","volume":"15","author":"A Dubin","year":"2025","unstructured":"Dubin A (2025) Effects of fluids on sublingual microcirculation: a point of view review. Ann Intensive Care 15:178","journal-title":"Ann Intensive Care"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-026-00983-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:02:39Z","timestamp":1791676959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-026-00983-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1186\/s40635-026-00983-5","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"25 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}